generics
Merck, Reckitt Benckiser fined by French watchdog
December 20, 2013Manufacturing and Production, Sales and Marketing FCA, Merck, Reckitt Benckiser, generics, subutex
Merck & Co and Reckitt Benckiser have collectively been fined millions of euros by French authorities over their role in …
Teva boss quits over Board struggles
October 31, 2013Medical Communications, Sales and Marketing Copaxone, Levin, Teva, generics
Teva’s president and chief executive Dr Jeremy Levin has unexpectedly quit as the firm struggles with staff cuts and management …
Viagra patent expiry opens up market
June 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing ED, Pfizer, generics, viagra
Pfizer lost its UK patent rights to its erectile dysfunction drug Viagra over the weekend, leading to an influx of …
Ranbaxy unit fined $500m for selling adulterated drugs
May 14, 2013Manufacturing and Production FDA, GMP, Ranbaxy, fine, generics
Ranbaxy’s US subsidiary has agreed to pay fines and penalties totalling $500 million after pleading guilty to charges of manufacturing …
Novartis’ 2012 results flat
January 24, 2013Sales and Marketing Bexsero, Jakavi, Novartis, generics, results
Generic competition has put a dent in Novartis’ financial results for 2012, with net sales down 3% year on year …
India plans ban on branded generics
October 18, 2012Manufacturing and Production, Sales and Marketing India, generics
India is moving ahead with plans to ban the sale of branded generics in the country, adding to marketplace concerns …
Pharma is recovering, says Moody’s
September 25, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Moody's, Plavix, austerity, generics, pharma
Credit ratings agency Moody’s believes that the travails of the past few years, when various big-selling drugs went off-patent, are …
Pfizer and Hisun sign China generics deal
September 13, 2012Manufacturing and Production, Sales and Marketing China, Pfizer, branded generics, emerging markets, generics
Pfizer has unveiled a new joint venture with with China’s Zhejiang Hisun Pharmaceuticals. It is one of the first joint …
Pfizer and Mylan sign Japanese generics deal
August 23, 2012Sales and Marketing Mylan, Pfizer, generics
Pfizer and Mylan have struck a deal to sell generic drugs together in Japan, the world’s second biggest pharma market. …
Novartis’ Indian patent case delayed
August 23, 2012Sales and Marketing Glivec, MSF, Novartis, generics
Novartis’ court case against the Indian government has been put on hold until next month. The case was suppose to …
GSK sheds Australian generics unit for £172m
August 15, 2012Sales and Marketing Aspen Global, GSK, generics
GlaxoSmithKline has divested the majority of its Australian generics unit to Aspen Global, a firm it partly owns. The South …
Former Teva president joins Sun Pharma
June 7, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Sun Pharma, Teva, generics, manufacturing
Sun Pharma has appointed Israel Makov as its new chairman of the board. Makov is the former president and chief …
Novartis to acquire Fougera for $1.5 billion
May 3, 2012Sales and Marketing Fougera, Novartis, dermatology, generics, gilenya
Novartis will acquire the dermatology generics firm Fougera for $1.53 billion in cash. Novartis’ generic unit Sandoz is conducting the …
Watson buys Actavis to create generics giant
April 27, 2012Sales and Marketing Actavis, Watson, generics
Watson Pharmaceuticals is to buy rival Actavis Group in a move that will create the third largest generics manufacturer in …
Novartis Q1 earnings slide down
April 26, 2012Sales and Marketing Novartis, Q1, Sandoz, generics, gilenya
Generic competition and problems at a US plant were among the reasons why Novartis’ sales and profit dipped in the …
Latest content
Five Facts about cardiovascular disease
